Red X iconGreen tick iconYellow tick icon

Chris Florkowski

BA, MB BS, MD(Lond), MRCP(UK), FRCPA, FRACP

Email chris.florkowski@cdhb.health.nz

Associate Professor Chris Florkowski is the convener of Clinical Chemistry for the Pathology Vertical Module.

He is also a Clinical Biochemist at the Canterbury Health Laboratories.

Publications

Li, B., Elston, M., Moore, J., du Toit, S., Potter, H., Ranasinghe, I., & Florkowski, C. (2024). Discordant thyroid function tests: Beware of albumin variants. New Zealand Medical Journal/Te ara tika o te hauora hapori, 137(1588), 90-93. Retrieved from https://nzmj.org.nz/

Hughes, R. C. E., Phillips, I., Florkowski, C. M., & Gullam, J. (2023). The predictive value of the sFlt-1/PlGF ratio in suspected preeclampsia in a New Zealand population: A prospective cohort study. Australian & New Zealand Journal of Obstetrics & Gynaecology, 63, 34-41. doi: 10.1111/ajo.13549

Li, B., Falvey, J., Pike, L., Sies, C., Chapman, P., & Florkowski, C. (2022). A case of macroenzyme aspartate aminotransferase (macro-AST) in a patient with seronegative rheumatoid arthritis. New Zealand Medical Journal, 135(1558), 106-109. Retrieved from https://journal.nzma.org.nz

Hughes, R., Phillips, I., Florkowski, C., & Gullam, J. (2022). Diabetes in pregnancy: Using the Sflt-1/PLGF ratio to predict preeclampsia. Proceedings of the 45th New Zealand Society for the Study of Diabetes (NZSSD) Annual Scientific Meeting. (pp. 18). Retrieved from https://www.ivvy.com.au/event/NZSSD22/welcome.html

Moore, J. A., Li, B. V., Wang, D., Chan, B., King, R. I., & Florkowski, C. M. (2022). Hƅ Westport [β121 (GH4) Glu>Asp; HBB:c.366A>C]: A novel β-globin variant interfering with HƅA1c measurement. Clinical Biochemistry, 107, 62-66. doi: 10.1016/j.clinbiochem.2022.05.003

Back to top